Par Drugs & Chemical Stock Screener | Share Price & Fundamental Analysis
PAR
Pharmaceuticals
Share Price NSE
₹91.06
▼
-0.07 (-0.08%)
As of April 28, 2026, the Par Drugs & Chemical share price (NSE: PAR) is ₹91.06, down 0.08% from the previous close, with shares trading between ₹90.56 and ₹92.74, and a 52-week range of ₹78.58–₹110.81.
Browse PAR cash flow statement to support your investment research.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Par Drugs & Chemical Market Cap
₹114.15 Cr.
PAR P/E Ratio (TTM)
8.21
Par Drugs & Chemical P/B Ratio
1.07
EPS (TTM)
₹10.86
Dividend Yield
-
Debt to Equity
-
PAR 52 Week High
₹110.81
Par Drugs & Chemical 52 Week Low
₹78.58
Operating Margin
17.00%
Profit Margin
12.61%
PAR Revenue (TTM)
₹111.00
EBITDA
₹23.00
Net Income
₹14.00
Total Assets
₹119.00
Total Equity
₹99.00
Par Drugs & Chemical Share Price History - Stock Screener Chart
Screen PAR historical share price movements with interactive charts. Analyze price trends and patterns.
Par Drugs & Chemical Company Profile - Fundamental Screener
Screen Par Drugs & Chemical company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for PAR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE04LG01015
Par Drugs & Chemical Balance Sheet Screener
Screen PAR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Total Assets | 119 | 102 | 89 | 79 | 76 | 60 | 51 | 54 | 56 |
| Current Assets | 55 | 60 | 49 | 44 | 41 | 24 | 14 | 14 | 14 |
| Fixed Assets | 39 | 41 | 38 | 34 | 30 | 34 | 36 | 39 | 42 |
| Liabilities | |||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 4 | 4 | 4 | 4 | 8 | 9 | 10 | 16 | 17 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||||
| Total Equity | 99 | 86 | 71 | 60 | 52 | 41 | 29 | 21 | 20 |
| Share Capital | 12 | 12 | 12 | 12 | 6 | 6 | 5 | 9 | 9 |
| Reserves & Surplus | 87 | 73 | 59 | 48 | 46 | 35 | 25 | 13 | 11 |
Par Drugs & Chemical Income Statement Screener - Profit & Revenue Analysis
Screen Par Drugs & Chemical income statement and profit fundamentals.
Analyze PAR quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Par Drugs & Chemical share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 111 | 103 | 96 | 96 | 75 | 61 | 56 | 46 | 42 | 49 |
| Expenses | 88 | 82 | 73 | 78 | 59 | 45 | 46 | 38 | 34 | 40 |
| EBITDA | 23 | 22 | 23 | 18 | 16 | 16 | 10 | 8 | 8 | 9 |
| Operating Profit % | 17.00% | 19.00% | 24.00% | 19.00% | 22.00% | 26.00% | 17.00% | 18.00% | 19.00% | 18.00% |
| Depreciation | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Interest | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 3 |
| Profit Before Tax | 19 | 18 | 20 | 15 | 13 | 15 | 6 | 3 | 3 | 3 |
| Tax | 5 | 5 | 5 | 4 | 4 | 3 | 1 | 1 | 1 | 2 |
| Net Profit | 14 | 13 | 15 | 11 | 9 | 12 | 5 | 3 | 2 | 2 |
| EPS | 11.30 | 10.86 | 11.78 | 9.21 | 7.49 | 18.87 | 7.75 | 5.60 | 5.64 | 6.50 |
Par Drugs & Chemical Cash Flow Screener - Liquidity Fundamentals
Screen PAR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 16 | 20 | 13 | 8 | 12 | 8 | 2 | 4 | 9 | 7 |
| Investing Activities | -25 | -6 | -7 | -3 | 0 | -2 | 0 | -1 | -2 | 0 |
| Financing Activities | 0 | 0 | 0 | -10 | 2 | 1 | -2 | -4 | -8 | -6 |
| Net Cash Flow | -9 | 14 | 6 | -5 | 14 | 7 | 0 | 0 | -1 | 1 |
Par Drugs & Chemical Shareholding Pattern Screener
See Par Drugs & Chemical shareholding pattern with promoter, FII, and DII holdings.
Check Par Drugs & Chemical promoter holding and ownership changes for PAR on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 73.37% | 73.37% | 73.37% | 73.41% | 74.21% | 74.21% | 73.37% | 73.37% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 20.30% | 20.26% | 20.27% | 20.03% | 20.46% | 20.09% | 19.42% | 22.86% |
| Other Holding | 6.33% | 6.37% | 6.37% | 6.56% | 5.34% | 5.71% | 7.21% | 3.77% |
| Shareholder Count | 15,472 | 14,887 | 14,280 | 13,761 | 7,403 | 8,022 | 8,757 | 17,199 |
Par Drugs & Chemical Share Dividend Screener - Share Yield Analysis
Check Par Drugs & Chemical dividend history with payout and yield data.
View Par Drugs & Chemical dividend details including ex-dates and amounts for PAR stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹2.50 | 4.04% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Par Drugs & Chemical Stock Index Membership
See which indices include Par Drugs & Chemical stock.
Check PAR index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Par Drugs & Chemical Market Events Screener - Corporate Actions
Get Par Drugs & Chemical corporate actions including splits, bonuses, and buybacks.
Check Par Drugs & Chemical stock events that may affect PAR share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 2.55% | ||
| 2026-02-10 | 2026-02-10 | Quarterly Result Announcement | NA | 7.71% |
| 2025-12-31 | 2025-12-31 | Extraordinary General Meeting | NA | -14.97% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | -4.43% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -8.56% |
| 2025-05-08 | 2025-05-08 | Quarterly Result Announcement | NA | -0.65% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -14.79% |
| 2025-02-12 | 2025-02-12 | Extraordinary General Meeting | NA | -9.70% |
| 2025-02-05 | 2025-02-05 | Extraordinary General Meeting | NA | -2.49% |
| 2024-10-22 | 2024-10-22 | Quarterly Result Announcement | NA | 5.27% |
| 2021-11-22 | 2021-11-23 | Dividend | ₹ 1.25 /share | -32.38% |
| 2021-04-27 | 2021-04-28 | Bonus | 1:1 | 3.44% |
Par Drugs & Chemical Competitors Screener - Peer Comparison
Screen PAR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 403,112 | 36.57 | 54,729 | 9.71% | 10,980 | 42.76 |
| Divis Laboratories | 169,329 | 67.34 | 9,712 | 18.67% | 2,191 | 64.61 |
| Torrent Pharmaceuticals | 140,360 | 60.79 | 11,539 | 6.99% | 1,911 | 48.05 |
| Dr Reddys Laboratories | 111,091 | 18.39 | 33,741 | 16.73% | 5,725 | 65.07 |
| Lupin | 107,012 | 22.59 | 22,910 | 13.74% | 3,306 | 57.36 |
| Cipla | 105,488 | 22.01 | 28,410 | 7.12% | 5,291 | 64.00 |
| Zydus Life Science | 95,225 | 18.61 | 23,511 | 18.55% | 4,615 | 63.05 |
| Mankind Pharma | 94,652 | 51.17 | 12,744 | 20.90% | 2,007 | 72.17 |
| Aurobindo Pharma | 83,368 | 23.68 | 32,346 | 9.43% | 3,484 | 73.85 |
| Alkem Laboratories | 66,006 | 27.67 | 13,458 | 3.70% | 2,216 | 52.98 |
Par Drugs & Chemical Company Announcements - News Screener
Screen PAR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-08 | Disclosure under SEBI Takeover Regulations | - |
| 2026-04-07 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | - |
| 2026-03-26 | Trading Window | - |
| 2026-03-26 | Action(s) taken or orders passed | - |
| 2026-02-11 | Copy of Newspaper Publication | - |
| 2026-02-10 | Outcome of Board Meeting | - |
| 2026-02-10 | Outcome of Board Meeting | - |
| 2026-02-10 | Outcome of Board Meeting | - |
| 2026-02-10 | Updates | - |
| 2026-01-23 | Updates | - |
| 2026-01-06 | Certificate under SEBI (Depositories and Participants) Regulations, 2018 | - |
| 2025-12-29 | Trading Window | - |
| 2025-12-13 | Action(s) taken or orders passed | - |
| 2025-11-14 | Copy of Newspaper Publication | - |
| 2025-11-13 | Updates | - |
| 2025-11-13 | Outcome of Board Meeting | - |
| 2025-11-13 | Outcome of Board Meeting | - |
| 2025-11-13 | Outcome of Board Meeting | - |
| 2025-11-03 | Copy of Newspaper Publication | - |
| 2025-10-27 | Action(s) taken or orders passed | - |